Fresenius Medical Care Completes Acquisition of NxStage Medical
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
National Cardiovascular Partners (NCP) helps physicians create, sustain, and grow ambulatory surgery centers (ASCs) and office-based laboratories. Our focus is outpatient, hybrid cardiovascular centers in partnership with physician entrepreneurs.
In 2007, we created the hybrid ASC/office-based lab model and have since built, acquired, grown, and optimized twenty-six outpatient surgery centers in seven states. We manage the entire development process from inception to completion of your center.
Our mission is to provide superior quality healthcare services that: patients recommend to families and friends, physicians prefer for their patients, and in which employees take pride.
BETTER QUALITY PATIENT CARE
To ensure the highest quality of patient care, NCP centers are designed from the ground up by physicians who understand what patients need most. Without the traditional volume constraints associated with hospitals, patients enjoy enhanced continuity of care, better communication and education, shorter wait times, easy parking, and more personalized service. The admission process is efficient, and patients typically can move from the window to the table in less than twenty minutes. In addition, because the centers are not inside hospitals, patients are not unnecessarily exposed to triage and emergency care cases.
A SUSTAINABLE MODEL WITH FREEDOM TO GROW
NCP offers a sustainable model that gives physicians the ability to supplement their income by investing in a broader range of services beyond their typical cases. With NCP's proven model of success, coupled with individual physicians' input into their own centers, the long-term viability and profitability are increased over traditional hospital options. Additionally, the centers are set up to be scalable, allowing for future growth based on market needs.
A SMART INVESTMENT
Creating a technologically advanced, patient-friendly hybrid center with NCP gives physicians the very real opportunity to invest in their field—and in their future. With a direct impact on the quality of service and overall patient experience, this is one investment that gives physicians more control over traditional investment opportunities. As majority owners, the physician partners maintain complete clinical and administrative control, allowing them to benefit for years to come.
NCP holds itself to a high standard in respect to safety and quality. Our highly trained staff uses modern equipment and always puts our patients' safety first. All NCP centers and labs are Joint Commission-accredited, and all NCP ASCs are Medicare-certified.
National Cardiovascular Partners (NCP) is the pioneer of the Hybrid Cardiovascular Center model (ASC & Catheterization Lab). Learn how they have successfully partnered with top physicians who are interested in having more professional control and the freedom to provide high-quality patient care.
It’s not hyperbole to say that in the past few years, the healthcare industry has undergone seismic shifts. As the population ages and Americans continue to live longer, the strains on the current system are likely to increase significantly. The urgency of reforming healthcare has become a political hot button as members of Congress debate on how to rein in the costs of what has become the most expensive healthcare system in the world.
Nowhere is this more evident than in the surgical outpatient arena. Advances in technology and more sophisticated surgical procedures have emboldened patients to demand more convenient and cost-effective care. As a result, hospital admissions have steadily declined, and ambulatory surgery centers (ASCs) are popping up everywhere.
National Cardiovascular Partners has been at the forefront of the movement toward safe and effective outpatient care for nearly a decade. Our skilled partner physicians and their dedicated staffs have performed well over 100,000 minimally invasive cardiovascular and endovascular procedures, including heart catheterizations, stent placements, and pacemaker insertions. In the hands of our experts, our patients enjoy extremely low complication and infection rates, and report extremely high overall satisfaction rates. How do we know? We meticulously track each and every procedural outcome, enabling us to share best practices throughout our organization and set the highest standards for the industry.
And in many ways, we are just getting started.
Earlier this year, the Centers for Medicare and Medicaid Studies (CMS) took an important step in updating the rules governing allowable payments in an outpatient setting by proposing a revision to their definition of “surgery” to include more codes outside the Current Procedural Terminology (CPT) surgical range. In addition, they also strongly signaled a willingness to include, in a future rulemaking, a number of the percutaneous coronary intervention procedures by specifically requesting feedback on these procedure codes. These procedures are currently only permissible in a hospital setting.
What does this mean? If approved, patients will no longer have to navigate a complicated and antiquated system and endure multiple procedures in multiple locations for safe and effective cardiovascular care. In other words, even more patients will be able to choose when, where, and how their procedures can be performed!
As both the national medical director for NCP and a practicing cardiologist for 20 years, I have seen firsthand how this outpatient movement has benefited and will continue to benefit our patients, from reduced costs to greater convenience and most importantly, better clinical results.
From a business perspective, the NCP model not only enables me to provide the highest quality of care to my patients without the administrative headaches that accompany a thriving practice, but also affords me greater flexibility with my schedule and a greater earning potential.
As technology continues to evolve and patients demand more say in their care, the outpatient trend is certain to continue. If you are interested in learning more about creating and growing your own hybrid ASC-Cath lab, with full clinical control and no administrative headaches, stop by our booth (#40G) at the upcoming Becker’s ASC Annual Meeting in Chicago on October 18–20, visit the NCP website, or give us a call (651) 846-8792 — we’d love to chat.
Pioneer of the Hybrid Cardiovascular Center Model Offers Physicians More Flexible Schedule and Joint Venture Opportunities
Neptune Beach, FL — MedAxiom, the nation’s leading cardiovascular healthcare membership organization and performance community, is excited to announce its corporate partnership with National Cardiovascular Partners (NCP), an organization working with physicians who want more professional control and freedom to provide high quality patient care through the hybrid cardiovascular center model.
“NCP is a national leader in ambulatory surgery center (ASC) and office based lab (OBL) design, development, and management,” said Joseph Sasson, Executive Vice President, MedAxiom Ventures. “As the outpatient strategy for cardiology will certainly see more of a shift to ASCs and OBLs in the coming years, we want to make sure that MedAxiom members are aware of the possibilities these locations of service offer and keep them up to date on the relevant regulations and coding changes in these settings. We are confident that MedAxiom’s partnership with NCP will help us to better meet the needs of our constituents in these areas.”
Since 2006, National Cardiovascular Partners has partnered with over 300 physicians and together they operate 23 outpatient Cardiovascular Centers in Texas, Arizona, Louisiana, Kansas, Florida and California, with a procedural mix that includes diagnostic catheterizations, peripheral interventions, vascular access procedures, PCI and AICD/pacemaker implantation. In 2014, NCP officially became part of Fresenius Medical Care North America, a multinational healthcare organization with a network of more than 2,400 dialysis facilities, vascular access centers and labs throughout the United States, Mexico and Canada.
“NCP is excited to enter into a corporate partnership with MedAxiom and share our outpatient success strategies with the cardiovascular community,” said Chad Ronis, Marketing and Communications Manager, NCP. “We are committed to the physicians’ priorities of outstanding clinical outcomes, efficient care and the growth of a business in an environment of collaboration.”
NCP’s physician partners performed over 17,000 procedures in our Cardiovascular Centers in 2017, with a patient satisfaction rate of 98.5%. These procedures included more than 3200+ pacemaker and defibrillator implants/ generator changes, nearly 7,000 cardiac catheterizations, 3,600+ peripheral interventions, and 7,500+ interventional cardiology cases. Labs are equipped with fixed Angio Suite C-arm equipment allowing providers to safely perform many of the same procedures completed in a hospital-based catheterization lab.
“I have had the opportunity to work with the National Cardiovascular Partners team since 2012,” said Denzil G. D’Souza, MD, FACC, FSCAI, Interventional & General Cardiology, Director, Heart & Vascular Center of Fort Worth, President & CEO, Fort Worth Heart, P.A. “They have been instrumental in planning, developing and managing the outpatient cardiovascular procedural center of which I am the director. I have found the NCP Team to be highly professional, effective and a pleasure to work with. They fully understand that the highest quality of care is the number one priority for physicians and support every measure to deliver the same to our patients. NCP’s understanding of the contractual and business aspects of outpatient cardiovascular procedural management is excellent and has been a real asset. Furthermore, NCP also provides a conduit and logistical support to interact with and be impactful on healthcare policy.”
MedAxiom members will have an opportunity to learn more about NCP at the CV Transforum Fall’18 conference, October 11-13, in Austin, TX, where they will be exhibiting.
MedAxiom is the nation’s leading cardiovascular performance community, providing expert consulting, networking and membership services including data analytics, program excellence tools and educational events. MedAxiom offers countless resources for all sectors of the cardiovascular health care industry and can connect its members, colleagues and the media with CV expertise to help advance the industry. The privately-held company was founded in 2001 by Jennifer Linville and is based in Neptune Beach, FL. For additional information, visit: http://www.medaxiom.com.
National Cardiovascular Partners is part of Fresenius Medical Care North America, and partners with physicians to create, sustain and grow their independent ambulatory surgery center and catheterization lab. Their focus is hybrid surgery center and outpatient cardiac catheterization lab services in partnership with physician entrepreneurs. They created the hybrid ASC-Cath Lab model in 2006 and since then have built, acquired, grown, and optimized 23 outpatient surgery centers to operate at the highest and most efficient level.
Learn more about NCP at https://fmcna.com/national-cardiovascular-partners/